- $4.98m
- $12.43m
- $1.73m
Brief: VolitionRX Offers 4.4 mln Shares of Common Stock at Price To Public Of $2.75/Shr
Brief: Volitionrx Announces Proposed Underwritten Public Offering Of Common Stock
Brief: Volitionrx Limited Announces First Quarter 2020 Financial Results And Business Update
Brief: Volition Files Patent For Nu.Q(Tm) Covid-19 Triage Test And Commences Proof Of Concept Studies
AMEX RESUMED
AMEX RESUMED
Brief: Volitionrx Limited Reports Cash And Cash Equivalents As Of Dec. 31, 2019 Totaled $17 Mln
Brief: VolitionRX Files Prospectus Related To Sale/ Other Disposition From Time To Time Of Up To 9.8 Million Shares Of Common Stock Held By Selling Stockholders
Brief: VolitionRx Limited Announces Strategic Acquisition
Brief: VolitionRx, Gyros Protein Awarded $1 Mln Grant To Collaborate On Lung Cancer Blood Test
Brief: VolitionRx Announces Proof Of Concept Data In Lymphoma And Leukemia
Brief: VolitionRX Limited Says Q3 Cash And Cash Equivalents As Of September 30, 2019 Totaled $19.7 Million
Brief: Volition Announces $500,000 In Non-Dilutive Funding For Volition Veterinary And Issues Video
U.S. STOCKS ON THE MOVE-Wynn Resorts, Netflix, Marathon Oil, Vitamin Shoppe
AMEX RESUMED
AMEX HALT ADDITIONAL INFORMATION LAST 5.050000
Brief: Volitionrx Limited Announces Q2 2019 Financial Results And Business Update
Brief: Volition Forms Texas-Based Veterinary Subsidiary And Appoints Its Chief Executive Officer
Brief: Volition Announces Exercise Of Warrant To Purchase $4.8 Mln In Common Stock